Front Matter
Show Items
Solution/Suspension/Syrup
Acetazolamide Suspension 25 mg/mL—Formulation 1
Acetazolamide Suspension 25 mg/mL—Formulation 2
Acetylcysteine Solution 10 mg/mL
Acetylcysteine Solution 100 mg/mL
Allopurinol Suspension 20 mg/mL—Formulation 1
Allopurinol Suspension 20 mg/mL—Formulation 2
Amiodarone Hydrochloride Suspension 5 mg/mL—Formulation 1*
Amiodarone Hydrochloride Suspension 5 mg/mL—Formulation 2
Amitriptyline Hydrochloride Suspension 10 mg/mL
Amitriptyline Hydrochloride Suspension 20 mg/mL
Amitriptyline Hydrochloride Syrup 1 mg/mL
Amphetamine and Dextroamphetamine (Adderall) Suspension 1 mg/mL
Atenolol Suspension 1 mg/mL
Atenolol Suspension 5 mg/mL
Atenolol Syrup 2 mg/mL—Formulation 1*
Atenolol Syrup 2 mg/mL—Formulation 2*
Atropine Sulfate Suspension 0.1 mg/mL
Azathioprine Suspension 50 mg/mL
Benazepril Hydrochloride Suspension 2 mg/mL
Bethanechol Chloride Solution 1 mg/mL
Bethanechol Chloride Suspension 5 mg/mL*
Buspirone Hydrochloride Syrup 2.5 mg/mL
Busulfan Syrup 2 mg/mL
Candesartan Cilexetil Suspension 1 mg/mL
Captopril Solution 1 mg/mL*
Captopril Suspension 0.75 mg/mL
Captopril Suspension 0.8 mg/mL
Captopril Suspension 1 mg/mL
Carvedilol Suspension 0.1 mg/mL
Carvedilol Suspension 1.67 mg/mL
Carvedilol Suspension 5 mg/mL
Celecoxib Suspension 10 mg/mL—Formulation 1
Celecoxib Suspension 10 mg/mL—Formulation 2
Chloroquine Phosphate Suspension 15 mg/mL—Formulation 1
Chloroquine Phosphate Suspension 15 mg/mL—Formulation 2
Chloroquine Phosphate Syrup 16.7 mg/mL*
Chlorpromazine Hydrochloride Syrup 100 mg/mL
Cinacalcet Suspension 5 mg/mL
Clonazepam Suspension 0.1 mg/mL
Clonazepam Suspension 0.2 mg/mL
Clonidine Hydrochloride Suspension 0.01 mg/mL
Clonidine Hydrochloride Syrup 0.02 mg/mL*
Clonidine Hydrochloride Syrup 0.1 mg/mL
Clopidogrel Bisulfate Suspension 5 mg/mL
Codeine Phosphate Syrup 3 mg/mL
Cyclophosphamide Suspension 10 mg/mL
Dantrolene Sodium Syrup 5 mg/mL
Dapsone Suspension 2 mg/mL—Formulation 1
Dapsone Suspension 2 mg/mL—Formulation 2
Dapsone Syrup 2 mg/mL
Diclofenac Sodium Suspension 5 mg/mL
Diltiazem Hydrochloride Suspension 12 mg/mL
Diltiazem Suspension 12 mg/mL
Dipyridamole Suspension 10 mg/mL—Formulation 1
Dipyridamole Suspension 10 mg/mL—Formulation 2
Disopyramide Syrup 1 mg/mL
Disopyramide Syrup 10 mg/mL
Dolasetron Mesylate Suspension 10 mg/mL
Erlotinib Suspension 10 mg/mL
Eslicarbazepine Acetate Suspension 40 mg/mL
Ethacrynic Acid Solution 1 mg/mL
Etoposide Solution 10 mg/mL
Flecainide Acetate Suspension 20 mg/mL—Formulation 1*
Flecainide Acetate Suspension 20 mg/mL—Formulation 2
Flucytosine Suspension 10 mg/mL
Flucytosine Suspension 50 mg/mL*
Glutamine Suspension 250 mg/mL
Granisetron Hydrochloride Suspension 0.05 mg/mL
Granisetron Hydrochloride Syrup 0.2 mg/mL
Hydralazine Hydrochloride Suspension 4 mg/mL*
Hydrochlorothiazide Suspension 2 mg/mL
Hydrocortisone Hemisuccinate Suspension 2 mg/mL
Hydrocortisone Sodium Phosphate Suspension 2 mg/mL
Hydrocortisone Suspension 1 mg/mL—Formulation 1
Hydrocortisone Suspension 1 mg/mL—Formulation 2
Hydrocortisone Suspension 2 mg/mL*
Hydroxychloroquine Sulfate Suspension 25 mg/mL
Hydroxyurea Syrup 100 mg/mL*
Hypromellose Suspension 10 mg/mL
Imatinib Syrup 40 mg/mL
Imipramine Hydrochloride Suspension 5 mg/mL
Indinavir Liquid 10 mg/mL
Isradipine Syrup 1 mg/mL
Ketoconazole Suspension 20 mg/mL—Formulation 1
Ketoconazole Suspension 20 mg/mL—Formulation 2
Ketoprofen Suspension 20 mg/mL
Labetalol Hydrochloride Suspension 40 mg/mL—Formulation 1*
Labetalol Hydrochloride Suspension 40 mg/mL—Formulation 2
Labetalol Hydrochloride Syrup 10 mg/mL
Lamotrigine Suspension 1 mg/mL—Formulation 1
Lamotrigine Suspension 1 mg/mL—Formulation 2
Lansoprazole Solution 3 mg/mL*
Lansoprazole Suspension 3 mg/mL
Lapatinib Suspension 50 mg/mL
Lenalidomide Suspension 1.25 mg/mL
Losartan Suspension 2.5 mg/mL
Melatonin Suspension 1 mg/mL
Melatonin Suspension 3 mg/mL
Melatonin 1 mg/mL and Pyridoxine Hydrochloride 3.3 mg/mL Suspension
Methylcellulose Suspension 10 mg/mL (1%)
Methyldopa Syrup 50 mg/mL
Metolazone Suspension 1 mg/mL
Metoprolol Tartrate Suspension 10 mg/mL—Formulation 1*
Metoprolol Tartrate Suspension 10 mg/mL—Formulation 2
Metronidazole Suspension 10 mg/mL
Metronidazole Suspension 50 mg/mL*
Metronidazole Syrup 5 mg/mL—Formulation 1
Metronidazole Syrup 5 mg/mL—Formulation 2
Mexiletine Solution 10 mg/mL
Minocycline Hydrochloride Suspension 10 mg/mL
Minoxidil Suspension 1 mg/mL
Moxifloxacin Suspension 20 mg/mL
Naratriptan Hydrochloride Suspension 0.5 mg/mL
Nifedipine Solution 10 mg/mL
Nifedipine Suspension 1 mg/mL
Nifedipine Suspension 4 mg/mL—Formulation 1*
Nifedipine Suspension 4 mg/mL—Formulation 2
Olmesartan Medoxomil Suspension 2 mg/mL
Omeprazole Solution 2 mg/mL
Omeprazole Suspension 2 mg/mL
Oxandrolone Suspension 1 mg/mL
Oxandrolone Suspension 2 mg/mL
Oxandrolone Suspension 3 mg/mL
Pantoprazole Solution 2 mg/mL—Formulation 1
Pantoprazole Solution 2 mg/mL—Formulation 2
Penicillamine-D Suspension 50 mg/mL
Pentoxifylline Solution 20 mg/mL
Phenoxybenzamine Hydrochloride Solution 2 mg/mL
Procainamide Hydrochloride Suspension 50 mg/mL
Propylthiouracil Suspension 5 mg/mL—Formulation 1
Propylthiouracil Suspension 5 mg/mL—Formulation 2
Pyrazinamide Suspension 10 mg/mL
Pyrazinamide Suspension 100 mg/mL
Pyrazinamide Syrup 100 mg/mL*
Pyridoxine Hydrochloride Suspension 50 mg/mL
Pyrimethamine Suspension 2 mg/mL—Formulation 1
Pyrimethamine Suspension 2 mg/mL—Formulation 2
Quinapril Syrup 1 mg/mL
Quinidine Sulfate Suspension 10 mg/mL—Formulation 1
Riboflavin Suspension 10 mg/mL
Rifabutin Suspension 20 mg/mL
Rifampin Suspension 25 mg/mL—Formulation 1*
Rifampin Suspension 25 mg/mL—Formulation 2
Rifampin Syrup 10 mg/mL
Rifaximin Suspension 20 mg/mL
Rosuvastatin Suspension 4 mg/mL
Sodium Benzoate Syrup 250 mg/mL
Sodium Phenylbutyrate Suspension 200 mg/mL
Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 1
Spironolactone 5 mg/mL and Hydrochlorothiazide 5 mg/mL Suspension—Formulation 2
Sulfadiazine Suspension 100 mg/mL
Sulfasalazine Suspension 100 mg/mL—Formulation 1
Sulfasalazine Suspension 100 mg/mL—Formulation 2
Sumatriptan Succinate Suspension 5 mg/mL
Sunitinib Malate Suspension 10 mg/mL
Tacrolimus Monohydrate Suspension 0.5 mg/mL
Tacrolimus Monohydrate Suspension 1 mg/mL
Tacrolimus Suspension 0.5 mg/mL
Tacrolimus Suspension 1 mg/mL*
Tadalafil Suspension 5 mg/mL
Temozolomide Suspension 10 mg/mL
Terbinafine Hydrochloride Suspension 25 mg/mL
Terbinafine Suspension 25 mg/mL
Terbutaline Sulfate Syrup 1 mg/mL
Tetracycline Hydrochloride Suspension 25 mg/mL—Formulation 1
Tetracycline Hydrochloride Suspension 25 mg/mL—Formulation 2
Thalidomide Suspension 20 mg/mL
Thiamine Suspension 100 mg/mL
Thioguanine Suspension 20 mg/mL*
Tiagabine Hydrochloride Suspension 1 mg/mL—Formulation 1
Tiagabine Hydrochloride Suspension 1 mg/mL—Formulation 2
Tinidazole Syrup 66.7 mg/mL
Topiramate Suspension 5 mg/mL
Tramadol Hydrochloride Suspension 5 mg/mL
Tramadol Hydrochloride Suspension 10 mg/mL
Tramadol Hydrochloride 7.5 mg/mL and Acetaminophen 65 mg/mL Suspension
Ursodiol Suspension 20 mg/mL
Ursodiol Suspension 25 mg/mL
Ursodiol Suspension 30 mg/mL
Ursodiol Suspension 50 mg/mL
Ursodiol Syrup 60 mg/mL—Formulation 1*
Ursodiol Syrup 60 mg/mL—Formulation 2*
Valacyclovir Hydrochloride Suspension 50 mg/mL*
Valsartan Suspension 4 mg/mL—Formulation 1
Valsartan Suspension 4 mg/mL—Formulation 2
Verapamil Hydrochloride Suspension 50 mg/mL
Ziprasidone Mesylate Syrup 2.5 mg/mL
Zonisamide Suspension 10 mg/mL—Formulation 1
Zonisamide Suspension 10 mg/mL—Formulation 2
Zonisamide Syrup 10 mg/mL*
Topical/Ophthalmic Solution
Show Items
Commercially Available Products (Use Only if Commercially Unavailable)
Show Items
Back Matter
Show Items
  • 1.

    General Chapter <795> Pharmaceutical Compounding—Nonsterile Preparations. In: United States Pharmacopeia and National Formulary (USP 43-NF 38). Revised January 1, 2014. Rockville, MD: The United States Pharmacopeia Convention Inc; 2020.

  • 1.

    Proposed Revisions to <795> Pharmaceutical Compounding – Nonsterile Preparations. The United States Pharmacopeia Convention Inc; 2021. Available at: https://go.usp.org/l/323321/2021-08-31/5kmcjf/323321/1630438802OI493yjz/BUD_Scientific_Rationale_for_the_2021_Proposed_Revisions_to__795_.docx. Accessed November 15, 2021.

  • 1.

    Pancorbo SA, Campagna KD, Devenport JK, et al.Task force report of competency statements for pharmacy practice. Am J Pharm Educ. 1987; 51:196–206.

    • Search Google Scholar
    • Export Citation
  • 2.

    Allen LV Jr. Establishing and marketing your extemporaneous compounding service. US Pharm. 1990; 15(Dec):74–7.

  • 3.

    Remington's pharmaceutical sciences. 18th ed. Gennaro AR, ed. Easton, PA: Mack Publishing; 1990; 1630–1, 1658, 1660.

  • 4.

    The United States Pharmacopeia, 22nd rev., and The National Formulary, 17th ed. Rockville, MD: The United States Pharmacopeial Convention; 1989.

    • Search Google Scholar
    • Export Citation
  • 5.

    USP DI Volume III: Approved drug products and legal requirements. 14th ed. Rockville, MD: The United States Pharmacopeial Convention; 1994.

    • Search Google Scholar
    • Export Citation
  • 6.

    USP DI Volume I: Drug information for the health care professional. 14th ed. Rockville, MD: The United States Pharmacopeial Convention; 1994.

    • Search Google Scholar
    • Export Citation
  • 7.

    29 §C.F.R. 1910. 1200(1990).

  • 8.

    ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990; 47:1033–49.

  • 9.

    Feinberg JL. Complying with OSHA's Hazard Communication Standard. Consult Pharm. 1991; 6:444, 446, 448.

  • 10.

    Myers CE. Applicability of OSHA Hazard Communication Standard to drug products. Am J Hosp Pharm. 1990; 47:1960–1.

  • 11.

    21 C.F.R. §211.137.

  • 12.

    Connors KA, Amidon GL, Stella VJ. Chemical stability of pharmaceuticals: a handbook for pharmacists. 2nd ed. New York: Wiley; 1986.

  • 13.

    American Society of Hospital Pharmacists. ASHP guidelines on preventing medication errors in hospitals. Am J Hosp Pharm. 1993; 50:305–14.

    • Search Google Scholar
    • Export Citation
  • 14.

    Fitzgerald WL Jr. The legal authority to compound in pharmacy practice. Tenn Pharm. 1990; 26(Mar):21–2.

  • 1.

    Associated Press. Pittsburgh woman loses eye to tainted drugs; 12 hurt. Baltimore Sun. 1990; Nov 9:3A.

  • 2.

    Associated Press. Eye drop injuries prompt an FDA warning. N Y Times. 1990; 140(Dec 9):39I.

  • 3.

    Jeglum EL, Rosenberg SB, Benson WE. Preparation of intravitreal drug doses. Ophthalmic Surg. 1981; 12:355–9.

  • 4.

    Reynolds LA. Guidelines for preparation of sterile ophthalmic products. Am J Hosp Pharm. 1991; 48:2438–9.

  • 5.

    Reynolds LA, Closson R. Ophthalmic drug formulations. A handbook of extemporaneous products. Vancouver, WA: Applied Therapeutics; 1993.

  • 6.

    The United States Pharmacopeia, 22nd rev., and The National Formulary, 17th ed. Rockville, MD: The United States Pharmacopeial Convention; 1989:1692–3.

  • 7.

    Allen LV. Indomethacin 1% ophthalmic suspension. US Pharm. 1991; 16(May):82–3.

  • 8.

    American Society of Hospital Pharmacists. ASHP technical assistance bulletin on handling cytotoxic and hazardous drugs. Am J Hosp Pharm. 1990; 47:1033–49.

    • Search Google Scholar
    • Export Citation
  • 9.

    OSHA work-practice guidelines for personnel dealing with cytotoxic (antineoplastic) drugs. Am J Hosp Pharm. 1986; 43:1193–204.

  • 10.

    Ansel HC, Popovich NG. Pharmaceutical dosage forms and drug delivery systems. 5th ed. Philadelphia: Lea & Febiger; 1990:354–7.

  • 11.

    Stolar MH. Expiration dates of repackaged drug products. Am J Hosp Pharm. 1979; 36:170. Editorial.

  • 12.

    Remington's pharmaceutical sciences. 19th ed. Gennaro AR, ed. Easton, PA: Mack Publishing; 1990:1581–959.

Quinidine Sulfate Suspension 10 mg/mL—Formulation 2

in Extemporaneous Formulations
DOI:
https://doi.org/10.37573/9781585286522.140
Restricted access